HEADER HYDROLASE/HYDROLASE INHIBITOR 26-AUG-10 3OLE TITLE STRUCTURES OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH TITLE 2 ACARVIOSTATIN II03 CAVEAT 3OLE ACI A 501 HAS WRONG CHIRALITY AT ATOM C1 ACI A 504 HAS WRONG CAVEAT 2 3OLE CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANCREATIC ALPHA-AMYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PA, 1,4-ALPHA-D-GLUCAN GLUCANOHYDROLASE; COMPND 5 EC: 3.2.1.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AMY2A; SOURCE 6 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 7 EXPRESSION_SYSTEM_COMMON: YEAST; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS GLYCOSYLATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, ACARVIOSTATIN KEYWDS 2 II03 EXPDTA X-RAY DIFFRACTION AUTHOR X.QIN,L.REN REVDAT 5 01-NOV-23 3OLE 1 HETSYN REVDAT 4 29-JUL-20 3OLE 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 25-OCT-17 3OLE 1 CAVEAT HETSYN LINK ATOM REVDAT 2 27-APR-11 3OLE 1 KEYWDS REMARK SITE REVDAT 1 13-APR-11 3OLE 0 JRNL AUTH X.QIN,L.REN,X.YANG,F.BAI,L.WANG,P.GENG,G.BAI,Y.SHEN JRNL TITL STRUCTURES OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH JRNL TITL 2 ACARVIOSTATINS: IMPLICATIONS FOR DRUG DESIGN AGAINST TYPE II JRNL TITL 3 DIABETES. JRNL REF J.STRUCT.BIOL. V. 174 196 2011 JRNL REFN ISSN 1047-8477 JRNL PMID 21111049 JRNL DOI 10.1016/J.JSB.2010.11.020 REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1836671.960 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 67254 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3410 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9599 REMARK 3 BIN R VALUE (WORKING SET) : 0.1930 REMARK 3 BIN FREE R VALUE : 0.2030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 542 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3939 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 181 REMARK 3 SOLVENT ATOMS : 530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.02000 REMARK 3 B22 (A**2) : 1.35000 REMARK 3 B33 (A**2) : -2.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.14 REMARK 3 ESD FROM SIGMAA (A) : 0.07 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.16 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.05 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.180 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.880 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.590 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.260 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 48.14 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : PCA.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : PCA.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3OLE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061262. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67254 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 26.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: 1B2Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 60% 2-METHYLPENTAN-2,4 DIOL, 100MM REMARK 280 CACODYLATE PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.16250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.49050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.94050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.49050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.16250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.94050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 31 -56.40 -140.71 REMARK 500 MET A 102 -137.20 -113.38 REMARK 500 ASP A 317 49.49 -106.20 REMARK 500 SER A 414 -108.21 -132.43 REMARK 500 ASP A 433 41.98 -88.89 REMARK 500 PRO A 486 37.43 -74.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ACARVIOSTATIN II03 IS COMPOSED OF RESIDUE 501-507 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 497 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 100 OD1 REMARK 620 2 ARG A 158 O 157.6 REMARK 620 3 ASP A 167 OD2 126.4 75.9 REMARK 620 4 ASP A 167 OD1 81.6 117.2 50.5 REMARK 620 5 HIS A 201 O 75.6 82.0 157.0 140.9 REMARK 620 6 HOH A 744 O 105.2 70.7 96.7 135.7 81.5 REMARK 620 7 HOH A 918 O 70.9 123.3 75.3 76.3 123.4 65.6 REMARK 620 8 HOH A 919 O 99.5 77.4 87.1 70.8 82.1 145.8 146.8 REMARK 620 N 1 2 3 4 5 6 7 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OLD RELATED DB: PDB REMARK 900 RELATED ID: 3OLG RELATED DB: PDB DBREF 3OLE A 1 496 UNP P04746 AMYP_HUMAN 16 511 SEQADV 3OLE MET A 287 UNP P04746 VAL 302 ENGINEERED MUTATION SEQRES 1 A 496 GLN TYR SER PRO ASN THR GLN GLN GLY ARG THR SER ILE SEQRES 2 A 496 VAL HIS LEU PHE GLU TRP ARG TRP VAL ASP ILE ALA LEU SEQRES 3 A 496 GLU CYS GLU ARG TYR LEU ALA PRO LYS GLY PHE GLY GLY SEQRES 4 A 496 VAL GLN VAL SER PRO PRO ASN GLU ASN VAL ALA ILE TYR SEQRES 5 A 496 ASN PRO PHE ARG PRO TRP TRP GLU ARG TYR GLN PRO VAL SEQRES 6 A 496 SER TYR LYS LEU CYS THR ARG SER GLY ASN GLU ASP GLU SEQRES 7 A 496 PHE ARG ASN MET VAL THR ARG CYS ASN ASN VAL GLY VAL SEQRES 8 A 496 ARG ILE TYR VAL ASP ALA VAL ILE ASN HIS MET CYS GLY SEQRES 9 A 496 ASN ALA VAL SER ALA GLY THR SER SER THR CYS GLY SER SEQRES 10 A 496 TYR PHE ASN PRO GLY SER ARG ASP PHE PRO ALA VAL PRO SEQRES 11 A 496 TYR SER GLY TRP ASP PHE ASN ASP GLY LYS CYS LYS THR SEQRES 12 A 496 GLY SER GLY ASP ILE GLU ASN TYR ASN ASP ALA THR GLN SEQRES 13 A 496 VAL ARG ASP CYS ARG LEU THR GLY LEU LEU ASP LEU ALA SEQRES 14 A 496 LEU GLU LYS ASP TYR VAL ARG SER LYS ILE ALA GLU TYR SEQRES 15 A 496 MET ASN HIS LEU ILE ASP ILE GLY VAL ALA GLY PHE ARG SEQRES 16 A 496 LEU ASP ALA SER LYS HIS MET TRP PRO GLY ASP ILE LYS SEQRES 17 A 496 ALA ILE LEU ASP LYS LEU HIS ASN LEU ASN SER ASN TRP SEQRES 18 A 496 PHE PRO ALA GLY SER LYS PRO PHE ILE TYR GLN GLU VAL SEQRES 19 A 496 ILE ASP LEU GLY GLY GLU PRO ILE LYS SER SER ASP TYR SEQRES 20 A 496 PHE GLY ASN GLY ARG VAL THR GLU PHE LYS TYR GLY ALA SEQRES 21 A 496 LYS LEU GLY THR VAL ILE ARG LYS TRP ASN GLY GLU LYS SEQRES 22 A 496 MET SER TYR LEU LYS ASN TRP GLY GLU GLY TRP GLY PHE SEQRES 23 A 496 MET PRO SER ASP ARG ALA LEU VAL PHE VAL ASP ASN HIS SEQRES 24 A 496 ASP ASN GLN ARG GLY HIS GLY ALA GLY GLY ALA SER ILE SEQRES 25 A 496 LEU THR PHE TRP ASP ALA ARG LEU TYR LYS MET ALA VAL SEQRES 26 A 496 GLY PHE MET LEU ALA HIS PRO TYR GLY PHE THR ARG VAL SEQRES 27 A 496 MET SER SER TYR ARG TRP PRO ARG GLN PHE GLN ASN GLY SEQRES 28 A 496 ASN ASP VAL ASN ASP TRP VAL GLY PRO PRO ASN ASN ASN SEQRES 29 A 496 GLY VAL ILE LYS GLU VAL THR ILE ASN PRO ASP THR THR SEQRES 30 A 496 CYS GLY ASN ASP TRP VAL CYS GLU HIS ARG TRP ARG GLN SEQRES 31 A 496 ILE ARG ASN MET VAL ILE PHE ARG ASN VAL VAL ASP GLY SEQRES 32 A 496 GLN PRO PHE THR ASN TRP TYR ASP ASN GLY SER ASN GLN SEQRES 33 A 496 VAL ALA PHE GLY ARG GLY ASN ARG GLY PHE ILE VAL PHE SEQRES 34 A 496 ASN ASN ASP ASP TRP SER PHE SER LEU THR LEU GLN THR SEQRES 35 A 496 GLY LEU PRO ALA GLY THR TYR CYS ASP VAL ILE SER GLY SEQRES 36 A 496 ASP LYS ILE ASN GLY ASN CYS THR GLY ILE LYS ILE TYR SEQRES 37 A 496 VAL SER ASP ASP GLY LYS ALA HIS PHE SER ILE SER ASN SEQRES 38 A 496 SER ALA GLU ASP PRO PHE ILE ALA ILE HIS ALA GLU SER SEQRES 39 A 496 LYS LEU MODRES 3OLE ASN A 461 ASN GLYCOSYLATION SITE HET GLC B 1 11 HET G6D B 2 9 HET GLC C 1 12 HET GLC C 2 11 HET G6D C 3 9 HET GLC D 1 12 HET GLC D 2 11 HET GLC D 3 11 HET BGC E 1 12 HET GLC E 2 11 HET GLC E 3 11 HET CA A 497 1 HET CL A 498 1 HET SO4 A 499 5 HET NAG A 500 14 HET ACI A 501 12 HET ACI A 504 12 HET PCA A 511 8 HET MPD A 515 8 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM G6D ALPHA-D-QUINOVOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ACI 6-AMINO-4-HYDROXYMETHYL-CYCLOHEX-4-ENE-1,2,3-TRIOL HETNAM PCA PYROGLUTAMIC ACID HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN G6D ALPHA-D-QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOPYRANOSE; D- HETSYN 2 G6D QUINOVOSE; QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 GLC 8(C6 H12 O6) FORMUL 2 G6D 2(C6 H12 O5) FORMUL 5 BGC C6 H12 O6 FORMUL 6 CA CA 2+ FORMUL 7 CL CL 1- FORMUL 8 SO4 O4 S 2- FORMUL 9 NAG C8 H15 N O6 FORMUL 10 ACI 2(C7 H13 N O4) FORMUL 12 PCA C5 H7 N O3 FORMUL 13 MPD C6 H14 O2 FORMUL 14 HOH *530(H2 O) HELIX 1 1 ARG A 20 TYR A 31 1 12 HELIX 2 2 PRO A 57 GLN A 63 5 7 HELIX 3 3 ASN A 75 VAL A 89 1 15 HELIX 4 4 ASN A 120 ARG A 124 5 5 HELIX 5 5 SER A 132 PHE A 136 5 5 HELIX 6 6 ASP A 153 CYS A 160 1 8 HELIX 7 7 ARG A 161 THR A 163 5 3 HELIX 8 8 LYS A 172 GLY A 190 1 19 HELIX 9 9 ALA A 198 MET A 202 5 5 HELIX 10 10 TRP A 203 ASP A 212 1 10 HELIX 11 11 LYS A 243 PHE A 248 5 6 HELIX 12 12 PHE A 256 ARG A 267 1 12 HELIX 13 13 LYS A 268 GLU A 272 5 5 HELIX 14 14 LYS A 273 TRP A 280 5 8 HELIX 15 15 GLY A 281 GLY A 285 5 5 HELIX 16 16 PRO A 288 ASP A 290 5 3 HELIX 17 17 ASP A 300 GLY A 304 5 5 HELIX 18 18 THR A 314 TRP A 316 5 3 HELIX 19 19 ASP A 317 HIS A 331 1 15 HELIX 20 20 CYS A 384 ARG A 387 5 4 HELIX 21 21 TRP A 388 VAL A 401 1 14 HELIX 22 22 GLU A 493 LYS A 495 5 3 SHEET 1 A 9 SER A 12 LEU A 16 0 SHEET 2 A 9 GLY A 39 VAL A 42 1 O GLN A 41 N VAL A 14 SHEET 3 A 9 ARG A 92 ALA A 97 1 O TYR A 94 N VAL A 40 SHEET 4 A 9 GLY A 193 LEU A 196 1 O ARG A 195 N ALA A 97 SHEET 5 A 9 PHE A 229 GLN A 232 1 O PHE A 229 N PHE A 194 SHEET 6 A 9 ARG A 252 THR A 254 1 O ARG A 252 N GLN A 232 SHEET 7 A 9 ALA A 292 VAL A 294 1 O LEU A 293 N VAL A 253 SHEET 8 A 9 PHE A 335 SER A 340 1 O PHE A 335 N VAL A 294 SHEET 9 A 9 SER A 12 LEU A 16 1 N ILE A 13 O VAL A 338 SHEET 1 B 2 HIS A 101 GLY A 104 0 SHEET 2 B 2 LEU A 165 ASP A 167 -1 O LEU A 166 N CYS A 103 SHEET 1 C 2 PHE A 348 GLN A 349 0 SHEET 2 C 2 ASN A 352 ASP A 353 -1 O ASN A 352 N GLN A 349 SHEET 1 D 2 ASN A 362 ASN A 363 0 SHEET 2 D 2 VAL A 366 ILE A 367 -1 O VAL A 366 N ASN A 363 SHEET 1 E 4 PHE A 406 ASP A 411 0 SHEET 2 E 4 GLN A 416 ARG A 421 -1 O GLY A 420 N THR A 407 SHEET 3 E 4 GLY A 425 ASN A 430 -1 O PHE A 429 N VAL A 417 SHEET 4 E 4 PHE A 487 HIS A 491 -1 O ILE A 488 N VAL A 428 SHEET 1 F 2 PHE A 436 GLN A 441 0 SHEET 2 F 2 LYS A 474 ILE A 479 -1 O ILE A 479 N PHE A 436 SHEET 1 G 2 GLY A 447 CYS A 450 0 SHEET 2 G 2 LYS A 466 VAL A 469 -1 O ILE A 467 N TYR A 449 SHEET 1 H 2 LYS A 457 ILE A 458 0 SHEET 2 H 2 ASN A 461 CYS A 462 -1 O ASN A 461 N ILE A 458 SSBOND 1 CYS A 28 CYS A 86 1555 1555 2.03 SSBOND 2 CYS A 70 CYS A 115 1555 1555 2.03 SSBOND 3 CYS A 141 CYS A 160 1555 1555 2.04 SSBOND 4 CYS A 378 CYS A 384 1555 1555 2.03 SSBOND 5 CYS A 450 CYS A 462 1555 1555 2.03 LINK N TYR A 2 C PCA A 511 1555 1555 1.47 LINK ND2 ASN A 461 C1 NAG A 500 1555 1555 1.45 LINK N1 ACI A 501 C4 G6D B 2 1555 1555 1.45 LINK O4 ACI A 504 C1 GLC B 1 1555 1555 1.43 LINK N1 ACI A 504 C4 G6D C 3 1555 1555 1.45 LINK O4 GLC B 1 C1 G6D B 2 1555 1555 1.43 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.37 LINK O4 GLC C 2 C1 G6D C 3 1555 1555 1.43 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.39 LINK O4 GLC D 2 C1 GLC D 3 1555 1555 1.39 LINK O4 BGC E 1 C1 GLC E 2 1555 1555 1.39 LINK O4 GLC E 2 C1 GLC E 3 1555 1555 1.39 LINK OD1 ASN A 100 CA CA A 497 1555 1555 2.48 LINK O ARG A 158 CA CA A 497 1555 1555 2.51 LINK OD2 ASP A 167 CA CA A 497 1555 1555 2.57 LINK OD1 ASP A 167 CA CA A 497 1555 1555 2.62 LINK O HIS A 201 CA CA A 497 1555 1555 2.47 LINK CA CA A 497 O HOH A 744 1555 1555 2.68 LINK CA CA A 497 O HOH A 918 1555 1555 2.61 LINK CA CA A 497 O HOH A 919 1555 1555 2.63 CISPEP 1 ASN A 53 PRO A 54 0 -0.09 CISPEP 2 VAL A 129 PRO A 130 0 0.04 CRYST1 52.325 67.881 130.981 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019111 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014732 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007635 0.00000